Table 1.
Study schedule presenting an overview of all study activities.
| Study activities | 0 w | Baseline | 4 w | 10 w | 16 w | 28 w | 40 w | 52 w | 68 w | |
| Before treatment | ||||||||||
| Mapping and mammography | X | |||||||||
| Written informed consent | X | |||||||||
| Require histological samples (incl. mapping) and mammography results from referring hospital | X | |||||||||
| Imiquimod 5% cream | Start | Stop | ||||||||
| Consultation by phone | X | |||||||||
| Consultation at outpatient clinic of involved research clinic, containing: | X | X | X | X | X | X | X | |||
| Vulvar examination, measurement and photo documentation | X | X | X | X | ||||||
| VAS score | X | X | X | X | X | X | X | X | ||
| Tolerability questionnaire | X | X | X | |||||||
| Biopsy | X | X | X | |||||||
| EQ5D | X | X | X | |||||||
| DLQI | X | X | X | |||||||
| FSDS | X | X | X | |||||||
| Review patient diary | X | X | X | |||||||